rs77874543
|
TNFRSF13C
|
IMMUNODEFICIENCY, COMMON VARIABLE, 4
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs61756766
|
TNFRSF13C
|
Chronic Lymphocytic Leukemia
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results point to a possible association between the rs9514828 (CT vs. CC + TT; OR = 0.74; CI 95 % = 0.57; 0.97; p = 0.022) and rs1041569 (AT vs. AA + TT; OR = 0.72; CI 95 % = 0.54; 0.95; p = 0.021) of BAFF gene and rs61756766 (CC vs. CT; OR = 2.03; CI 95 % = 1.03; 3.99; p = 0.03) of BAFF-R gene and CLL risk.
|
27468724 |
2016 |
rs61756766
|
TNFRSF13C
|
Rheumatoid Arthritis
|
|
0.010 |
GeneticVariation |
BEFREE |
The corresponding frequencies of the His159Tyr BAFF-R mutation in SLE and RA patients were 3.5% and 3%, respectively.
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Sjogren's Syndrome
|
|
0.010 |
GeneticVariation |
BEFREE |
A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Adult Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Both the SS-lymphoma and SS-nonlymphoma patient subgroups exhibited significantly higher frequencies of the His159Tyr BAFF-R mutation compared to healthy controls (8.6% of SS-lymphoma patients and 6.2% of SS-nonlymphoma patients versus 1.7% of healthy controls; P = 0.02 and P = 0.04, respectively).
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Lupus Erythematosus, Systemic
|
|
0.010 |
GeneticVariation |
BEFREE |
The corresponding frequencies of the His159Tyr BAFF-R mutation in SLE and RA patients were 3.5% and 3%, respectively.
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Familial primary gastric lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
This study identifies an increased prevalence of the BAFF-R His159Tyr mutation in patients with SS, particularly in those with SS complicated by MALT lymphoma whose disease onset occurred at a younger age.
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Both the SS-lymphoma and SS-nonlymphoma patient subgroups exhibited significantly higher frequencies of the His159Tyr BAFF-R mutation compared to healthy controls (8.6% of SS-lymphoma patients and 6.2% of SS-nonlymphoma patients versus 1.7% of healthy controls; P = 0.02 and P = 0.04, respectively).
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Childhood Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Both the SS-lymphoma and SS-nonlymphoma patient subgroups exhibited significantly higher frequencies of the His159Tyr BAFF-R mutation compared to healthy controls (8.6% of SS-lymphoma patients and 6.2% of SS-nonlymphoma patients versus 1.7% of healthy controls; P = 0.02 and P = 0.04, respectively).
|
26097183 |
2015 |
rs61756766
|
TNFRSF13C
|
Mucosa-Associated Lymphoid Tissue Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
This study identifies an increased prevalence of the BAFF-R His159Tyr mutation in patients with SS, particularly in those with SS complicated by MALT lymphoma whose disease onset occurred at a younger age.
|
26097183 |
2015 |
rs77874543
|
TNFRSF13C
|
Sepsis
|
|
0.010 |
GeneticVariation |
BEFREE |
Interestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.
|
25454804 |
2015 |
rs77874543
|
TNFRSF13C
|
Septicemia
|
|
0.010 |
GeneticVariation |
BEFREE |
Interestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.
|
25454804 |
2015 |